Meet Alecia Wesner, a hero for T1D clinical trials
Since 2014, Alecia Wesner has participated in numerous T1D clinical trials, many of which were early artificial pancreas system trials.
Breakthrough T1D Mourns Tragic, Sudden Loss of Five Ride Champions
The leadership, staff, and volunteers of Breakthrough T1D mourn the recent loss of five T1D Champions.
Meet Liz Walsh, a hero for pregnancy with T1D
Thanks to advancements in type 1 diabetes treatment and care, Liz Walsh had a complication-free pregnancy with T1D.
Vertex launches pivotal trial for stem-cell derived islet therapy
On Monday, Vertex made a monumental announcement. Their Phase 1/2 trial for VX-880 is converting to a Phase 1/2/3 pivotal…
Fact-checking myths and misconceptions about type 1 diabetes
We take a look at some of the most common misconceptions about T1D and set the record straight!
FDA Advisory Committee does not recommend that sotagliflozin receive approval for glucose lowering in adults with type 1 diabetes (T1D) and Chronic Kidney Disease (CKD)
Update – November 22, 2024 This morning, Lexicon Pharmaceuticals, Inc. (Lexicon) announced they received a “deficiencies preclude discussion” letter from…
Novel way to protect transplanted cells shows promise
A novel immune therapy called tegoprubart made by Eledon Pharmaceuticals and being tested in kidney transplant patients has the potential…
Breakthrough T1D shares the latest research at ISPAD
At the 2024 International Society for Pediatric and Adolescent Diabetes (ISPAD) Conference in Lisbon, Portugal, the world’s leading diabetes researchers,…
Celebrating Halloween with type 1 diabetes
Tips for families on juggling type 1 diabetes with the super sweet fun of Halloween.
Breakthrough T1D and the Nobel Prizes: Connected!
It’s early October, which means the Nobel Prizes are being awarded in several categories. These prestigious awards recognize outstanding contributions…
